402 related articles for article (PubMed ID: 34483914)
1. Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2.
Hsu HY; Yang CW; Lee YZ; Lin YL; Chang SY; Yang RB; Liang JJ; Chao TL; Liao CC; Kao HC; Wu SH; Chang JY; Sytwu HK; Chen CT; Lee SJ
Front Pharmacol; 2021; 12():706901. PubMed ID: 34483914
[TBL] [Abstract][Full Text] [Related]
2. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
3. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
Molecules; 2020 May; 25(10):. PubMed ID: 32429580
[TBL] [Abstract][Full Text] [Related]
4. Optimizing human coronavirus OC43 growth and titration.
Savoie C; Lippé R
PeerJ; 2022; 10():e13721. PubMed ID: 35833016
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.
Yang CW; Lee YZ; Hsu HY; Jan JT; Lin YL; Chang SY; Peng TT; Yang RB; Liang JJ; Liao CC; Chao TL; Pang YH; Kao HC; Huang WZ; Lin JH; Chang CP; Niu GH; Wu SH; Sytwu HK; Chen CT; Lee SJ
Front Pharmacol; 2020; 11():606097. PubMed ID: 33519469
[TBL] [Abstract][Full Text] [Related]
6. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
Min JS; Kim DE; Jin YH; Kwon S
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32674356
[TBL] [Abstract][Full Text] [Related]
7. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
8. Improved plaque assay for human coronaviruses 229E and OC43.
Bracci N; Pan HC; Lehman C; Kehn-Hall K; Lin SC
PeerJ; 2020; 8():e10639. PubMed ID: 33391888
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
10. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Human Coronaviruses by Antimalarial Peroxides.
Ghosh AK; Miller H; Knox K; Kundu M; Henrickson KJ; Arav-Boger R
ACS Infect Dis; 2021 Jul; 7(7):1985-1995. PubMed ID: 33783182
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses.
Ordonez AA; Bullen CK; Villabona-Rueda AF; Thompson EA; Turner ML; Davis SL; Komm O; Powell JD; D'Alessio FR; Yolken RH; Jain SK; Jones-Brando L
bioRxiv; 2021 Mar; ():. PubMed ID: 33791708
[TBL] [Abstract][Full Text] [Related]
13. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Antiviral Activity of Remdesivir, Chloroquine, and Interferon-β as Single or Dual Agents Against the Human Beta-Coronavirus OC43.
Hickerson BT; Sheikh F; Donnelly RP; Ilyushina NA
J Interferon Cytokine Res; 2023 Jan; 43(1):35-42. PubMed ID: 36651846
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Nucleoside Analogs for Human Coronaviruses.
Zandi K; Amblard F; Musall K; Downs-Bowen J; Kleinbard R; Oo A; Cao D; Liang B; Russell OO; McBrayer T; Bassit L; Kim B; Schinazi RF
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122172
[TBL] [Abstract][Full Text] [Related]
16. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b.
Lee YZ; Hsu HY; Yang CW; Lin YL; Chang SY; Yang RB; Liang JJ; Chao TL; Liao CC; Kao HC; Chang JY; Sytwu HK; Chen CT; Lee SJ
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890406
[TBL] [Abstract][Full Text] [Related]
17. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
[TBL] [Abstract][Full Text] [Related]
19. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
[TBL] [Abstract][Full Text] [Related]
20. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2021; 12():687449. PubMed ID: 34322120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
